For example, ESoo2033, a CD39 inhibitor, stabilizes extracellular anti-inflammatory ATP and disrupts the synthesis of immunosuppressive ADO within the TME, thereby restoring anti-tumor immunity 112. This evidence concerns the gene ADO and neoplasm.